Circ-ABCB10 Contributes to Paclitaxel Resistance in Breast Cancer Through Let-7a-5p/DUSP7 Axis

BACKGROUND: Paclitaxel (PTX) is one of the widely used chemotherapy drugs in breast cancer (BC) treatment. Unfortunately, the survival rate of metastatic BC patients remains poor due to PTX resistance. Therefore, uncovering the underlying mechanism behind the PTX resistance of BC cells is crucial fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Weiping, Gong, Piguo, Yang, Yifeng, Yang, Chunyan, Yang, Baohui, Ren, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108723/
https://www.ncbi.nlm.nih.gov/pubmed/32273769
http://dx.doi.org/10.2147/CMAR.S238513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108723/
https://www.ncbi.nlm.nih.gov/pubmed/32273769
http://dx.doi.org/10.2147/CMAR.S238513

Ejemplares similares